- A Case of Donor Cell Leukemia after Allogenic Peripheral Blood Stem Cell Transplantation for Acute Promyelocytic Leukemia with PML-RARA
-
Shin WY, Bang HI, Kim J, Kim KH, Won JH, Park R
- KMID: 2466771
- Lab Med Online.
- 2020 Jan;10(1):88-91.
- doi: 10.3343/lmo.2020.10.1.88
Donor cell leukemia (DCL), a rare but fatal complication arising from allogenic stem cell transplantation, is a complex disease associated with multiple pathophysiological processes. Specific diagnosis of DCL distinct from... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
-
Choi M, Shin DY, Lee JY, Kim I, Yoon SS, Bang SM
- KMID: 2466598
- Blood Res.
- 2019 Dec;54(4):290-295.
- doi: 10.5045/br.2019.54.4.290
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nutritional Intervention for a Patient with Acute Lymphoblastic Leukemia on Allogeneic Peripheral Blood Stem Cell Transplantation
-
Kim S, Kim S, Park Y, Shin AR, Yeom H
- KMID: 2417718
- Clin Nutr Res.
- 2018 Jul;7(3):223-228.
- doi: 10.7762/cnr.2018.7.3.223
Hematopoietic stem cell transplantation (HSCT) causes many complications such as anorexia, nausea, vomiting, diarrhea, and mucositis. Most patients undergoing HSCT have risk for malnutrition in the process of transplantation so... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation for Refractory Rheumatic Diseases
-
Lee S, Bae SC, Jun JB, Choi CB
- KMID: 2385342
- J Rheum Dis.
- 2017 Jun;24(3):149-156.
- doi: 10.4078/jrd.2017.24.3.149
OBJECTIVE: We investigated the long-term outcomes of autologous peripheral blood stem cell transplantation (PBSCT) to treat refractory rheumatic diseases. METHODS: Patients who underwent PBSCT for refractory rheumatic diseases at our institution... -
- CITED
-
- Close
- SHARE
-
- Close
- Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia
-
Sohn SK, Moon JH, Lee YJ, Park SW, Kim JY
- KMID: 2172744
- Blood Res.
- 2016 Mar;51(1):44-49.
- doi: 10.5045/br.2016.51.1.44
BACKGROUND: Most hypomethylating agent (HMA) responders with myelodysplastic syndrome (MDS) eventually need allogeneic stem cell transplantation (SCT) because they often acquire resistance to HMAs within two years of treatment. Considering... -
- CITED
-
- Close
- SHARE
-
- Close
- Pumpless extracorporeal interventional lung assist for bronchiolitis obliterans after allogenic peripheral blood stem cell transplantation for acute lymphocytic leukemia
-
Park YH, Chung CU, Choi JW, Jung SO, Jung SS, Lee JE, Kim JO, Moon JY
- KMID: 2319907
- Yeungnam Univ J Med.
- 2015 Dec;32(2):98-101.
- doi: 10.12701/yujm.2015.32.2.98
Bronchiolitis obliterans (BO), which is associated with graft-versus-host disease after allogenic hematopoietic stem cell transplantation, is a major obstacle to survival after bone marrow transplantation due to its gradual progress,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Remission of Renal Amyloidosis after Autologous Peripheral Blood Stem Cell Transplantation
-
An SY, Kim YH, Kwon YE, Kim YL, Nam KH, Choi H, Kim YJ, Park KS, Jeong HJ, Oh HJ, Park JT, Han SH, Kang SW, Yoo TH
- KMID: 1726731
- Ewha Med J.
- 2013 Dec;36(Suppl):S25-S29.
- doi: 10.12771/emj.2013.36.S.S25
Primary amyloidosis has unfavorable prognosis, particularly with organ involvement. Here, we report a case of clinical remission of renal amyloidosis after autologous hematopoietic cell transplantation. A 51-year-old female patient visited... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation in Pediatric Patients with High-risk Neuroblastoma
-
Kim S, Lee Y, Lyu CJ, Baek EJ, Kim HS, Lee K, Kim HO
- KMID: 1909659
- Korean J Blood Transfus.
- 2007 Dec;18(3):227-238.
BACKGROUND: High dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) has become standard therapy for high-risk neuroblastoma patients. We performed a retrospective analysis to assess the characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Day +11 Methotrexate on the Incidence of Graft-versus-host Disease after HLA-identical Allogeneic Peripheral Blood Stem Cell Transplantation
-
Ahn BM, Jung YR, Lee KB, Sohn SK, Kim JG, Baek JH, Cho YY, Chae YS, Jeon SB, Moon JH, Kim SN, Lee SJ, Suh JS, Lee KS
- KMID: 2083480
- Korean J Hematol.
- 2006 Jun;41(2):73-82.
- doi: 10.5045/kjh.2006.41.2.73
BACKGROUND: Cyclosporine (CSA) plus 4 doses of methotrexate (MTX) is the commonly used regimen for GVHD prophylaxis. It has been previously found that the omission of the day +11 dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Improved Survival in Neuroblastoma by Autologous Peripheral Blood Stem Cell Transplantation: A Single Institution Experience
-
Kim JY, Baek HJ, Han DK, Sung JS, Nam TK, Yoon MS, Kook H, Hwang TJ
- KMID: 2049207
- Clin Pediatr Hematol Oncol.
- 2006 Apr;13(1):9-21.
PURPOSE: Neuroblastoma is the most common extracranial solid tumor of childhood, and its outcome in advanced diseases has been very poor. We evaluated the treatment outcome and prognostic factors in... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduced Intensity Conditioning Regimen Followed by Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Panmyelosis with Myelofibrosis
-
Shim H, Lee YJ, Park MR
- KMID: 2083465
- Korean J Hematol.
- 2005 Dec;40(4):266-270.
- doi: 10.5045/kjh.2005.40.4.266
A 44-year-old male presented with a month history of exertional dyspnea and dizziness. A peripheral blood smear revealed a pancytopenia with 3% of blasts. We were not able to obtain... -
- CITED
-
- Close
- SHARE
-
- Close
- Thrombotic Thrombocytopenic Purpura after Autologous Peripheral Blood Stem Cell Transplantation
-
Kim MH
- KMID: 2038249
- Korean J Lab Med.
- 2005 Apr;25(2):129-132.
Thrombotic thombocytopenic purpura (TTP) is a serious complication following stem cell trans-plantation (SCT). Although therapeutic plasma exchange offers an encouraging treatment modality in classic TTP, this does not appear to... -
- CITED
-
- Close
- SHARE
-
- Close
- Allogeneic peripheral blood stem cell transplantation
-
Min WS
- KMID: 1652683
- Korean J Med.
- 2004 Apr;66(4):373-382.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Single Center Experience of Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia
-
Sung WJ, Moon JH, Jeon SB, Kim DH, Kim JG, Sohn SK, Suh JS, Lee KS, Lee KB
- KMID: 1637293
- Korean J Hematol.
- 2004 Mar;39(1):16-22.
BACKGROUND: Recently, peripheral blood (PB) stem cells have been used widely for allogeneic stem cell transplantation (SCT), instead of bone marrow (BM). The current study analyzed the outcome of allogeneic... -
- CITED
-
- Close
- SHARE
-
- Close
- Allogeneic Peripheral Blood Stem Cell Transplantation from An HLA-identical Sibling Donor in Children
-
Yoo KH, Min KW, Lee SH, Sung KW, Kim DW, Cho EJ, Koo HH
- KMID: 2278296
- Korean J Pediatr Hematol Oncol.
- 2003 Oct;10(2):214-222.
PURPOSE: G-CSF-mobilized peripheral blood is one of the sources of allogeneic hematopoietic stem cells. We report our experiences on allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from an HLA-identical sibling... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Scleroderma following Autologous Peripheral Stem Cell Transplantation
-
Choi WB, Kim YT, Cho MK, Lee JS, Whang KU
- KMID: 2250112
- Korean J Dermatol.
- 2003 Oct;41(10):1408-1410.
Generation of various autoantibodies and associated autoimmune diseases has been reported in allogeneic and autologous stem cell transplant recipients. We report a case of scleroderma following autologous peripheral blood stem... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Usefulness of the Hematopoietic Progenitor Cell Counts in Predicting the Optimal Timing of Peripheral Blood Stem Cell Harvest
-
Lee JL, Kim SB, Lee GW, Ryu MH, Kim EK, Kim S, Kim WK, Lee JS, Park KU, Suh C
- KMID: 1099789
- J Korean Med Sci.
- 2003 Feb;18(1):27-35.
- doi: 10.3346/jkms.2003.18.1.27
Although enumeration of CD34+ cells in the peripheral blood (PB) on the day of apheresis predicts the quantity of those cells collected, the flow cytometric techniques used are complex and... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed Ovarian Cancer
-
Kim SE, Won JH, Kim HS, Park JS, Kim CK, Lee KT, Park SK, Baick SH, Hong DS, Park HS, Kim HC
- KMID: 1568914
- Cancer Res Treat.
- 2002 Dec;34(6):439-443.
PURPOSE: High dose chemotherapy (HDC) is increasingly being used for ovarian cancer. Although early studies of autotransplantation for advanced ovarian cancer have been encouraging, most reported series were small, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Peripheral Blood Stem Cell Transplantation Using G-CSF Combined Conditioning in AML Patients
-
Kim BS, Kook H, Hwang TJ, Choi CW, Kim JS
- KMID: 1571392
- Immune Netw.
- 2002 Mar;2(1):49-52.
- doi: 10.4110/in.2002.2.1.49
BACKGROUND: The possibility that G-CSF recruits leukemic cells from the G0 to S phase, which may lead to a greater susceptibility to cytotoxic drugs, such as ara-C, has been presented... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Preemptive Therapy with Intravenous Ganciclovir Followed by Oral Ganciclovir against Cytomegalovirus Infection after Allogeneic Peripheral Blood Stem Cell Transplantation
-
Kim JG, Sung WJ, Che YS, Seo KW, Park SW, Jung JT, Sohn SK, Suh KS, Lee KB
- KMID: 2252427
- Korean J Hematol.
- 2002 Feb;37(1):31-37.
BACKGROUND: Recently, in vitro studies demonstrated faster immune reconstitution after allogeneic peripheral blood stem cell transplantation (PBSCT) compared to bone marrow transplantation (BMT). In consequence, it can be expected that... -
- CITED
-
- Close
- SHARE
-
- Close
